$BCP Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in BALCHEM CORP.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in BALCHEM CORP. Get notifications about new insider transactions in BALCHEM CORP for free.
Page: < prev 1 ... 2 3 4 5 6 7 8 9 ... 9 next >
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Sep 02 2011 | BCP | BALCHEM CORP | TELEVANTOS JOHN Y | Director | Grant | A | 6.78 | 3,000 | 20,340 | 48,040 | 45 K to 48 K (+6.66 %) |
May 10 2011 | BCP | BALCHEM CORP | Richardson Paul H | VP, R&D | Sell | S | 39.98 | 14,400 | 575,712 | 28,188 | 42.6 K to 28.2 K (-33.81 %) |
May 10 2011 | BCP | BALCHEM CORP | Richardson Paul H | VP, R&D | Buy | M | 13.61 | 14,400 | 195,984 | 42,588 | 28.2 K to 42.6 K (+51.09 %) |
May 20 2011 | BCP | BALCHEM CORP | TELEVANTOS JOHN Y | Director | Sell | S | 40.67 | 3,750 | 152,513 | 45,040 | 48.8 K to 45 K (-7.69 %) |
May 20 2011 | BCP | BALCHEM CORP | TELEVANTOS JOHN Y | Director | Grant | A | 6.78 | 3,750 | 25,425 | 48,790 | 45 K to 48.8 K (+8.33 %) |
Mar 23 2011 | BCP | BALCHEM CORP | Richardson Paul H | VP, R&D | Buy | M | 13.61 | 3,100 | 42,191 | 28,015 | 24.9 K to 28 K (+12.44 %) |
Mar 23 2011 | BCP | BALCHEM CORP | Richardson Paul H | VP, R&D | Buy | M | 11.87 | 400 | 4,748 | 24,915 | 24.5 K to 24.9 K (+1.63 %) |
Mar 23 2011 | BCP | BALCHEM CORP | Richardson Paul H | VP, R&D | Sell | S | 34.02 | 10,749 | 365,681 | 24,515 | 35.3 K to 24.5 K (-30.48 %) |
Mar 23 2011 | BCP | BALCHEM CORP | Richardson Paul H | VP, R&D | Buy | M | 11.87 | 10,749 | 127,591 | 35,264 | 24.5 K to 35.3 K (+43.85 %) |
Mar 08 2011 | BCP | BALCHEM CORP | Richardson Paul H | VP, Research & Deve ... | Sell | S | 35.58 | 1,553 | 55,256 | 24,515 | 26.1 K to 24.5 K (-5.96 %) |
Mar 08 2011 | BCP | BALCHEM CORP | Richardson Paul H | VP, Research & Deve ... | Buy | M | 11.87 | 1,553 | 18,434 | 26,068 | 24.5 K to 26.1 K (+6.33 %) |
Mar 08 2011 | BCP | BALCHEM CORP | Richardson Paul H | VP, Research & Deve ... | Sell | S | 35.50 | 4,798 | 170,329 | 24,515 | 29.3 K to 24.5 K (-16.37 %) |
Mar 08 2011 | BCP | BALCHEM CORP | Richardson Paul H | VP, Research & Deve ... | Buy | M | 11.87 | 4,798 | 56,952 | 29,313 | 24.5 K to 29.3 K (+19.57 %) |
Dec 14 2010 | BCP | BALCHEM CORP | MCMILLAN EDWARD | Director | Sell | S | 32.74 | 5,063 | 165,747 | 40,464 | 45.5 K to 40.5 K (-11.12 %) |
Dec 14 2010 | BCP | BALCHEM CORP | MCMILLAN EDWARD | Director | Buy | M | 3.73 | 5,063 | 18,885 | 45,527 | 40.5 K to 45.5 K (+12.51 %) |
Dec 09 2010 | BCP | BALCHEM CORP | WEDRAL ELAINE R | Director | Grant | A | 0.07 | 3,076 | 205 | 43,540 | 40.5 K to 43.5 K (+7.60 %) |
Dec 09 2010 | BCP | BALCHEM CORP | TELEVANTOS JOHN Y | Director | Grant | A | 0.07 | 3,076 | 205 | 45,040 | 42 K to 45 K (+7.33 %) |
Dec 09 2010 | BCP | BALCHEM CORP | ROSSI DINO A | President & CEO | Option Exercise | A | 32.21 | 34,800 | 1,120,908 | 32,500 | |
Dec 09 2010 | BCP | BALCHEM CORP | ROSSI DINO A | President & CEO | Payment of Exercise | F | 32.14 | 9,351 | 300,541 | 131,763 | 141.1 K to 131.8 K (-6.63 %) |
Dec 09 2010 | BCP | BALCHEM CORP | ROSSI DINO A | President & CEO | Grant | A | 0.07 | 7,230 | 482 | 141,114 | 133.9 K to 141.1 K (+5.40 %) |
Dec 09 2010 | BCP | BALCHEM CORP | Richardson Paul H | VP, Research & Deve ... | Option Exercise | A | 32.21 | 17,400 | 560,454 | 17,400 | |
Dec 09 2010 | BCP | BALCHEM CORP | Richardson Paul H | VP, Research & Deve ... | Payment of Exercise | F | 32.14 | 3,117 | 100,180 | 24,515 | 27.6 K to 24.5 K (-11.28 %) |
Dec 09 2010 | BCP | BALCHEM CORP | Richardson Paul H | VP, Research & Deve ... | Grant | A | 0.07 | 2,580 | 172 | 27,632 | 25.1 K to 27.6 K (+10.30 %) |
Dec 09 2010 | BCP | BALCHEM CORP | Premdas Perry W | Director | Grant | A | 0.07 | 3,076 | 205 | 35,215 | 32.1 K to 35.2 K (+9.57 %) |
Dec 09 2010 | BCP | BALCHEM CORP | MCMILLAN EDWARD | Director | Grant | A | 0.07 | 3,076 | 205 | 43,488 | 40.4 K to 43.5 K (+7.61 %) |
Dec 09 2010 | BCP | BALCHEM CORP | LUDWIG DAVID F | VP/Gen Mgr/ARC Spec ... | Option Exercise | A | 32.21 | 23,200 | 747,272 | 23,200 | |
Dec 09 2010 | BCP | BALCHEM CORP | LUDWIG DAVID F | VP/Gen Mgr/ARC Spec ... | Payment of Exercise | F | 32.14 | 2,078 | 66,787 | 27,296 | 29.4 K to 27.3 K (-7.07 %) |
Dec 09 2010 | BCP | BALCHEM CORP | LUDWIG DAVID F | VP/Gen Mgr/ARC Spec ... | Grant | A | 0.07 | 2,170 | 145 | 29,374 | 27.2 K to 29.4 K (+7.98 %) |
Dec 09 2010 | BCP | BALCHEM CORP | Houston Matthew David | General Counsel/Sec ... | Option Exercise | A | 32.21 | 5,300 | 170,713 | 5,300 | |
Dec 09 2010 | BCP | BALCHEM CORP | Houston Matthew David | General Counsel/Sec ... | Payment of Exercise | F | 32.14 | 815 | 26,194 | 9,540 | 10.4 K to 9.5 K (-7.87 %) |
Dec 09 2010 | BCP | BALCHEM CORP | Houston Matthew David | General Counsel/Sec ... | Grant | A | 0.07 | 1,030 | 69 | 10,355 | 9.3 K to 10.4 K (+11.05 %) |
Dec 09 2010 | BCP | BALCHEM CORP | FITZPATRICK FRANK | CFO | Option Exercise | A | 32.21 | 32,500 | 1,046,825 | 32,500 | |
Dec 09 2010 | BCP | BALCHEM CORP | FITZPATRICK FRANK | CFO | Payment of Exercise | F | 32.14 | 3,117 | 100,180 | 50,641 | 53.8 K to 50.6 K (-5.80 %) |
Dec 09 2010 | BCP | BALCHEM CORP | FITZPATRICK FRANK | CFO | Grant | A | 0.07 | 3,920 | 261 | 54,561 | 50.6 K to 54.6 K (+7.74 %) |
Dec 09 2010 | BCP | BALCHEM CORP | Fischer David B | Director | Grant | A | 0.07 | 3,076 | 205 | 4,076 | 1,000 to 4.1 K (+307.60 %) |
Dec 09 2010 | BCP | BALCHEM CORP | COOMBS PAUL D | Director | Grant | A | 0.07 | 3,076 | 205 | 3,076 | 0 to 3.1 K |
Dec 03 2010 | BCP | BALCHEM CORP | WEDRAL ELAINE R | Director | Sell | S | 31.60 | 3,216 | 101,626 | 40,464 | 43.7 K to 40.5 K (-7.36 %) |
Dec 03 2010 | BCP | BALCHEM CORP | WEDRAL ELAINE R | Director | Buy | M | 4.75 | 3,216 | 15,276 | 43,680 | 40.5 K to 43.7 K (+7.95 %) |
Dec 03 2010 | BCP | BALCHEM CORP | WEDRAL ELAINE R | Director | Sell | S | 31.62 | 2,669 | 84,394 | 40,464 | 43.1 K to 40.5 K (-6.19 %) |
Dec 03 2010 | BCP | BALCHEM CORP | WEDRAL ELAINE R | Director | Buy | M | 4.75 | 2,669 | 12,678 | 43,133 | 40.5 K to 43.1 K (+6.60 %) |
Dec 03 2010 | BCP | BALCHEM CORP | WEDRAL ELAINE R | Director | Sell | S | 31.64 | 3,209 | 101,533 | 40,464 | 43.7 K to 40.5 K (-7.35 %) |
Dec 03 2010 | BCP | BALCHEM CORP | WEDRAL ELAINE R | Director | Buy | M | 4.03 | 3,209 | 12,932 | 43,673 | 40.5 K to 43.7 K (+7.93 %) |
Dec 03 2010 | BCP | BALCHEM CORP | WEDRAL ELAINE R | Director | Sell | S | 31.58 | 1,854 | 58,549 | 40,464 | 42.3 K to 40.5 K (-4.38 %) |
Dec 03 2010 | BCP | BALCHEM CORP | WEDRAL ELAINE R | Director | Buy | M | 4.03 | 1,854 | 7,472 | 42,318 | 40.5 K to 42.3 K (+4.58 %) |
Nov 26 2010 | BCP | BALCHEM CORP | FITZPATRICK FRANK | CFO | Sell | S | 32.12 | 60,750 | 1,951,211 | 49,820 | 110.6 K to 49.8 K (-54.94 %) |
Nov 26 2010 | BCP | BALCHEM CORP | FITZPATRICK FRANK | CFO | Buy | M | 4.55 | 60,750 | 276,413 | 110,570 | 49.8 K to 110.6 K (+121.94 %) |
Nov 05 2010 | BCP | BALCHEM CORP | Richardson Paul H | VP, Research & Deve ... | Sell | S | 30.04 | 16,250 | 488,150 | 24,900 | 41.2 K to 24.9 K (-39.49 %) |
Nov 05 2010 | BCP | BALCHEM CORP | Richardson Paul H | VP, Research & Deve ... | Buy | M | 11.87 | 16,250 | 192,888 | 41,150 | 24.9 K to 41.2 K (+65.26 %) |
Nov 05 2010 | BCP | BALCHEM CORP | Richardson Paul H | VP, Research & Deve ... | Sell | S | 30.04 | 15,750 | 473,130 | 24,900 | 40.7 K to 24.9 K (-38.75 %) |
Nov 05 2010 | BCP | BALCHEM CORP | Richardson Paul H | VP, Research & Deve ... | Buy | M | 9.21 | 15,750 | 145,058 | 40,650 | 24.9 K to 40.7 K (+63.25 %) |
Nov 05 2010 | BCP | BALCHEM CORP | Richardson Paul H | VP, Research & Deve ... | Sell | S | 29.76 | 3,000 | 89,280 | 24,900 | 27.9 K to 24.9 K (-10.75 %) |
Nov 05 2010 | BCP | BALCHEM CORP | Richardson Paul H | VP, Research & Deve ... | Buy | M | 9.21 | 3,000 | 27,630 | 27,900 | 24.9 K to 27.9 K (+12.05 %) |
Sep 20 2010 | BCP | BALCHEM CORP | LUDWIG DAVID F | VP/Gen Mgr/ARC Spec ... | Sell | S | 28.11 | 40,900 | 1,149,515 | 26,990 | 67.9 K to 27 K (-60.24 %) |
Sep 20 2010 | BCP | BALCHEM CORP | LUDWIG DAVID F | VP/Gen Mgr/ARC Spec ... | Buy | M | 5.85 | 40,900 | 239,265 | 67,470 | 26.6 K to 67.5 K (+153.93 %) |
Sep 17 2010 | BCP | BALCHEM CORP | LUDWIG DAVID F | VP/Gen Mgr/ARC Spec ... | Sell | S | 28.18 | 3,990 | 112,438 | 26,990 | 31 K to 27 K (-12.88 %) |
Sep 17 2010 | BCP | BALCHEM CORP | LUDWIG DAVID F | VP/Gen Mgr/ARC Spec ... | Buy | M | 5.85 | 3,990 | 23,342 | 30,980 | 27 K to 31 K (+14.78 %) |
Sep 17 2010 | BCP | BALCHEM CORP | LUDWIG DAVID F | VP/Gen Mgr/ARC Spec ... | Sell | S | 27.33 | 6,510 | 177,918 | 26,990 | 33.5 K to 27 K (-19.43 %) |
Sep 17 2010 | BCP | BALCHEM CORP | LUDWIG DAVID F | VP/Gen Mgr/ARC Spec ... | Buy | M | 5.85 | 6,510 | 38,084 | 33,500 | 27 K to 33.5 K (+24.12 %) |
Sep 17 2010 | BCP | BALCHEM CORP | LUDWIG DAVID F | VP/Gen Mgr/ARC Spec ... | Sell | S | 27.33 | 13,490 | 368,682 | 26,990 | 40.5 K to 27 K (-33.33 %) |
Sep 17 2010 | BCP | BALCHEM CORP | LUDWIG DAVID F | VP/Gen Mgr/ARC Spec ... | Buy | M | 4.51 | 13,490 | 60,840 | 40,480 | 27 K to 40.5 K (+49.98 %) |
Sep 15 2010 | BCP | BALCHEM CORP | Houston Matthew David | General Counsel/Sec ... | Sell | S | 26.70 | 15,075 | 402,503 | 9,126 | 24.2 K to 9.1 K (-62.29 %) |
Sep 15 2010 | BCP | BALCHEM CORP | Houston Matthew David | General Counsel/Sec ... | Buy | M | 6.58 | 15,075 | 99,194 | 24,201 | 9.1 K to 24.2 K (+165.19 %) |
Aug 19 2010 | BCP | BALCHEM CORP | LUDWIG DAVID F | VP/Gen Mgr/ARC Spec ... | Sell | S | 26.00 | 9,710 | 252,460 | 26,990 | 36.7 K to 27 K (-26.46 %) |
Aug 19 2010 | BCP | BALCHEM CORP | LUDWIG DAVID F | VP/Gen Mgr/ARC Spec ... | Buy | M | 4.51 | 9,710 | 43,792 | 36,700 | 27 K to 36.7 K (+35.98 %) |
Aug 16 2010 | BCP | BALCHEM CORP | LUDWIG DAVID F | VP/Gen Mgr/ARC Spec ... | Sell | S | 26.00 | 500 | 13,000 | 26,990 | 27.5 K to 27 K (-1.82 %) |
Aug 16 2010 | BCP | BALCHEM CORP | LUDWIG DAVID F | VP/Gen Mgr/ARC Spec ... | Buy | M | 4.51 | 500 | 2,255 | 27,490 | 27 K to 27.5 K (+1.85 %) |
Aug 12 2010 | BCP | BALCHEM CORP | LUDWIG DAVID F | VP/Gen Mgr/ARC Spec ... | Sell | S | 26.82 | 16,800 | 450,576 | 26,990 | 43.8 K to 27 K (-38.36 %) |
Aug 12 2010 | BCP | BALCHEM CORP | LUDWIG DAVID F | VP/Gen Mgr/ARC Spec ... | Buy | M | 4.51 | 16,800 | 75,768 | 43,790 | 27 K to 43.8 K (+62.25 %) |
Aug 10 2010 | BCP | BALCHEM CORP | LUDWIG DAVID F | VP/Gen Mgr/ARC Spec ... | Sell | S | 27.05 | 6,800 | 183,940 | 26,990 | 33.8 K to 27 K (-20.12 %) |
Aug 10 2010 | BCP | BALCHEM CORP | LUDWIG DAVID F | VP/Gen Mgr/ARC Spec ... | Buy | M | 4.51 | 6,800 | 30,668 | 33,790 | 27 K to 33.8 K (+25.19 %) |
Aug 10 2010 | BCP | BALCHEM CORP | LUDWIG DAVID F | VP/Gen Mgr/ARC Spec ... | Sell | S | 27.14 | 1,300 | 35,282 | 26,990 | 28.3 K to 27 K (-4.60 %) |
Aug 10 2010 | BCP | BALCHEM CORP | LUDWIG DAVID F | VP/Gen Mgr/ARC Spec ... | Buy | M | 4.51 | 1,300 | 5,863 | 28,920 | 27.6 K to 28.9 K (+4.71 %) |
May 28 2010 | BCP | BALCHEM CORP | Richardson Paul H | VP, Research & Deve ... | Sell | S | 24.37 | 8,100 | 197,397 | 16,800 | 24.9 K to 16.8 K (-32.53 %) |
May 13 2010 | BCP | BALCHEM CORP | Houston Matthew David | General Counsel/Sec ... | Sell | S | 25.18 | 11,400 | 287,052 | 9,126 | 20.5 K to 9.1 K (-55.54 %) |
May 13 2010 | BCP | BALCHEM CORP | Houston Matthew David | General Counsel/Sec ... | Buy | M | 6.58 | 11,400 | 75,012 | 20,526 | 9.1 K to 20.5 K (+124.92 %) |
May 13 2010 | BCP | BALCHEM CORP | Houston Matthew David | General Counsel/Sec ... | Sell | S | 25.05 | 600 | 15,030 | 9,126 | 9.7 K to 9.1 K (-6.17 %) |
May 13 2010 | BCP | BALCHEM CORP | Houston Matthew David | General Counsel/Sec ... | Buy | M | 6.58 | 600 | 3,948 | 9,726 | 9.1 K to 9.7 K (+6.57 %) |
May 12 2010 | BCP | BALCHEM CORP | Richardson Paul H | VP, Research & Deve ... | Sell | S | 24.71 | 10,000 | 247,100 | 24,900 | 34.9 K to 24.9 K (-28.65 %) |
May 12 2010 | BCP | BALCHEM CORP | Richardson Paul H | VP, Research & Deve ... | Buy | M | 9.21 | 10,000 | 92,100 | 34,900 | 24.9 K to 34.9 K (+40.16 %) |
May 12 2010 | BCP | BALCHEM CORP | Richardson Paul H | VP, Research & Deve ... | Sell | S | 24.58 | 5,000 | 122,900 | 24,900 | 29.9 K to 24.9 K (-16.72 %) |
May 12 2010 | BCP | BALCHEM CORP | Richardson Paul H | VP, Research & Deve ... | Buy | M | 9.21 | 5,000 | 46,050 | 29,900 | 24.9 K to 29.9 K (+20.08 %) |
May 12 2010 | BCP | BALCHEM CORP | Richardson Paul H | VP, Research & Deve ... | Sell | S | 24.58 | 15,000 | 368,700 | 24,900 | 39.9 K to 24.9 K (-37.59 %) |
May 12 2010 | BCP | BALCHEM CORP | Richardson Paul H | VP, Research & Deve ... | Buy | M | 8.79 | 15,000 | 131,850 | 39,900 | 24.9 K to 39.9 K (+60.24 %) |
Jan 29 2010 | BCP | BALCHEM CORP | WEDRAL ELAINE R | Director | Grant | A | 0.07 | 3,226 | 215 | 26,976 | 23.8 K to 27 K (+13.58 %) |
Mar 19 2010 | BCP | BALCHEM CORP | Houston Matthew David | General Counsel/Sec ... | Sell | S | 24.81 | 1,500 | 37,215 | 9,024 | 10.5 K to 9 K (-14.25 %) |
Mar 19 2010 | BCP | BALCHEM CORP | Houston Matthew David | General Counsel/Sec ... | Buy | M | 6.58 | 1,500 | 9,870 | 10,524 | 9 K to 10.5 K (+16.62 %) |
Jan 29 2010 | BCP | BALCHEM CORP | TELEVANTOS JOHN Y | Director | Grant | A | 0.07 | 3,226 | 215 | 27,976 | 24.8 K to 28 K (+13.03 %) |
Jan 29 2010 | BCP | BALCHEM CORP | Premdas Perry W | Director | Grant | A | 0.07 | 3,226 | 215 | 21,426 | 18.2 K to 21.4 K (+17.73 %) |
Jan 29 2010 | BCP | BALCHEM CORP | MITCHELL KENNETH P | Director | Grant | A | 0.67 | 3,226 | 2,150 | 34,244 | 31 K to 34.2 K (+10.40 %) |
Jan 29 2010 | BCP | BALCHEM CORP | MCMILLAN EDWARD | Director | Grant | A | 0.07 | 3,226 | 215 | 26,941 | 23.7 K to 26.9 K (+13.60 %) |
Dec 11 2009 | BCP | BALCHEM CORP | ROSSI DINO A | President and CEO | Option Exercise | A | 32.08 | 30,000 | 962,400 | 30,000 | |
Dec 11 2009 | BCP | BALCHEM CORP | ROSSI DINO A | President and CEO | Grant | A | 0.07 | 7,000 | 467 | 105,725 | 98.7 K to 105.7 K (+7.09 %) |
Dec 11 2009 | BCP | BALCHEM CORP | Richardson Paul H | VP, Research & Deve ... | Option Exercise | A | 32.08 | 15,000 | 481,200 | 15,000 | |
Dec 11 2009 | BCP | BALCHEM CORP | Richardson Paul H | VP, Research & Deve ... | Grant | A | 0.07 | 2,500 | 167 | 21,779 | 19.3 K to 21.8 K (+12.97 %) |
Dec 11 2009 | BCP | BALCHEM CORP | LUDWIG DAVID F | VP/Gen Mgr/ARC Spec ... | Option Exercise | A | 32.08 | 20,000 | 641,600 | 20,000 | |
Dec 11 2009 | BCP | BALCHEM CORP | LUDWIG DAVID F | VP/Gen Mgr/ARC Spec ... | Grant | A | 0.07 | 2,100 | 140 | 17,735 | 15.6 K to 17.7 K (+13.43 %) |
Dec 11 2009 | BCP | BALCHEM CORP | Houston Matthew David | General Counsel/Sec ... | Option Exercise | A | 32.08 | 4,600 | 147,568 | 4,600 | |
Dec 11 2009 | BCP | BALCHEM CORP | Houston Matthew David | General Counsel/Sec ... | Grant | A | 0.00 | 1,000 | 0 | 5,842 | 4.8 K to 5.8 K (+20.65 %) |
Dec 11 2009 | BCP | BALCHEM CORP | FITZPATRICK FRANK | CFO | Option Exercise | A | 32.08 | 28,000 | 898,240 | 28,000 | |
Dec 11 2009 | BCP | BALCHEM CORP | FITZPATRICK FRANK | CFO | Grant | A | 0.07 | 3,800 | 253 | 32,768 | 29 K to 32.8 K (+13.12 %) |
Aug 05 2009 | BCP | BALCHEM CORP | LUDWIG DAVID F | VP/Gen Mgr/ARC Spec ... | Sell | S | 27.45 | 12,150 | 333,518 | 15,635 | 27.8 K to 15.6 K (-43.73 %) |
Aug 05 2009 | BCP | BALCHEM CORP | LUDWIG DAVID F | VP/Gen Mgr/ARC Spec ... | Buy | M | 6.83 | 12,150 | 82,985 | 27,785 | 15.6 K to 27.8 K (+77.71 %) |
Aug 05 2009 | BCP | BALCHEM CORP | FITZPATRICK FRANK | CFO | Sell | S | 26.87 | 3,110 | 83,566 | 28,968 | 32.1 K to 29 K (-9.70 %) |
Aug 05 2009 | BCP | BALCHEM CORP | FITZPATRICK FRANK | CFO | Buy | M | 6.77 | 3,110 | 21,055 | 32,078 | 29 K to 32.1 K (+10.74 %) |
Aug 05 2009 | BCP | BALCHEM CORP | FITZPATRICK FRANK | CFO | Sell | S | 27.21 | 22,515 | 612,633 | 28,968 | 51.5 K to 29 K (-43.73 %) |
Aug 05 2009 | BCP | BALCHEM CORP | FITZPATRICK FRANK | CFO | Buy | M | 6.77 | 22,515 | 152,427 | 51,483 | 29 K to 51.5 K (+77.72 %) |
Aug 05 2009 | BCP | BALCHEM CORP | FITZPATRICK FRANK | CFO | Sell | S | 27.40 | 25,000 | 685,000 | 28,968 | 54 K to 29 K (-46.32 %) |
Aug 05 2009 | BCP | BALCHEM CORP | FITZPATRICK FRANK | CFO | Buy | M | 6.77 | 25,000 | 169,250 | 53,968 | 29 K to 54 K (+86.30 %) |
Jun 04 2009 | BCP | BALCHEM CORP | ROSSI DINO A | President and CEO | Buy | M | 1.88 | 16,875 | 31,725 | 98,725 | 81.9 K to 98.7 K (+20.62 %) |
Jun 04 2009 | BCP | BALCHEM CORP | ROSSI DINO A | President and CEO | Sell | S | 25.11 | 25,157 | 631,692 | 81,850 | 107 K to 81.9 K (-23.51 %) |
Jun 04 2009 | BCP | BALCHEM CORP | ROSSI DINO A | President and CEO | Buy | M | 6.83 | 25,157 | 171,822 | 107,007 | 81.9 K to 107 K (+30.74 %) |
Jun 01 2009 | BCP | BALCHEM CORP | ROSSI DINO A | President and CEO | Sell | S | 24.41 | 23,440 | 572,170 | 81,850 | 105.3 K to 81.9 K (-22.26 %) |
Jun 01 2009 | BCP | BALCHEM CORP | ROSSI DINO A | President and CEO | Buy | M | 6.83 | 23,440 | 160,095 | 105,290 | 81.9 K to 105.3 K (+28.64 %) |
Jun 01 2009 | BCP | BALCHEM CORP | ROSSI DINO A | President and CEO | Sell | S | 23.94 | 18,903 | 452,538 | 81,850 | 100.8 K to 81.9 K (-18.76 %) |
Jun 01 2009 | BCP | BALCHEM CORP | ROSSI DINO A | President and CEO | Buy | M | 6.83 | 18,903 | 129,107 | 100,753 | 81.9 K to 100.8 K (+23.09 %) |
Jun 01 2009 | BCP | BALCHEM CORP | ROSSI DINO A | President and CEO | Sell | S | 23.94 | 13,341 | 319,384 | 81,850 | 95.2 K to 81.9 K (-14.01 %) |
Jun 01 2009 | BCP | BALCHEM CORP | ROSSI DINO A | President and CEO | Buy | M | 6.27 | 13,341 | 83,648 | 95,191 | 81.9 K to 95.2 K (+16.30 %) |
Jun 01 2009 | BCP | BALCHEM CORP | ROSSI DINO A | President and CEO | Sell | S | 24.15 | 17,795 | 429,749 | 81,850 | 99.6 K to 81.9 K (-17.86 %) |
Jun 01 2009 | BCP | BALCHEM CORP | ROSSI DINO A | President and CEO | Buy | M | 6.27 | 17,795 | 111,575 | 99,645 | 81.9 K to 99.6 K (+21.74 %) |
May 27 2009 | BCP | BALCHEM CORP | ROSSI DINO A | President and CEO | Sell | S | 24.56 | 17,000 | 417,520 | 81,850 | 98.9 K to 81.9 K (-17.20 %) |
May 27 2009 | BCP | BALCHEM CORP | ROSSI DINO A | President and CEO | Buy | M | 6.27 | 17,000 | 106,590 | 98,850 | 81.9 K to 98.9 K (+20.77 %) |
May 27 2009 | BCP | BALCHEM CORP | ROSSI DINO A | President and CEO | Sell | S | 25.07 | 19,364 | 485,455 | 81,850 | 101.2 K to 81.9 K (-19.13 %) |
May 27 2009 | BCP | BALCHEM CORP | ROSSI DINO A | President and CEO | Buy | M | 6.27 | 19,364 | 121,412 | 101,214 | 81.9 K to 101.2 K (+23.66 %) |
May 27 2009 | BCP | BALCHEM CORP | ROSSI DINO A | President and CEO | Sell | S | 25.07 | 11,918 | 298,784 | 81,850 | 93.8 K to 81.9 K (-12.71 %) |
May 27 2009 | BCP | BALCHEM CORP | ROSSI DINO A | President and CEO | Buy | M | 3.30 | 11,918 | 39,329 | 93,768 | 81.9 K to 93.8 K (+14.56 %) |
May 27 2009 | BCP | BALCHEM CORP | ROSSI DINO A | President and CEO | Sell | S | 24.15 | 11,707 | 282,724 | 81,850 | 93.6 K to 81.9 K (-12.51 %) |
May 27 2009 | BCP | BALCHEM CORP | ROSSI DINO A | President and CEO | Buy | M | 3.30 | 11,707 | 38,633 | 93,557 | 81.9 K to 93.6 K (+14.30 %) |
May 20 2009 | BCP | BALCHEM CORP | Richardson Paul H | VP, Research & Deve ... | Buy | M | 6.77 | 5,400 | 36,558 | 19,279 | 13.9 K to 19.3 K (+38.91 %) |
May 20 2009 | BCP | BALCHEM CORP | Richardson Paul H | VP, Research & Deve ... | Sell | S | 23.89 | 12,500 | 298,625 | 13,879 | 26.4 K to 13.9 K (-47.39 %) |
May 20 2009 | BCP | BALCHEM CORP | Richardson Paul H | VP, Research & Deve ... | Buy | M | 8.77 | 12,500 | 109,625 | 23,379 | 10.9 K to 23.4 K (+114.90 %) |
May 20 2009 | BCP | BALCHEM CORP | Richardson Paul H | VP, Research & Deve ... | Sell | S | 23.89 | 5,605 | 133,903 | 13,879 | 19.5 K to 13.9 K (-28.77 %) |
May 20 2009 | BCP | BALCHEM CORP | Richardson Paul H | VP, Research & Deve ... | Buy | M | 8.77 | 5,605 | 49,156 | 19,484 | 13.9 K to 19.5 K (+40.38 %) |
May 18 2009 | BCP | BALCHEM CORP | Richardson Paul H | VP, Research & Deve ... | Sell | S | 23.80 | 3,821 | 90,940 | 13,879 | 17.7 K to 13.9 K (-21.59 %) |
May 18 2009 | BCP | BALCHEM CORP | Richardson Paul H | VP, Research & Deve ... | Buy | M | 8.77 | 3,821 | 33,510 | 17,700 | 13.9 K to 17.7 K (+27.53 %) |
May 18 2009 | BCP | BALCHEM CORP | Richardson Paul H | VP, Research & Deve ... | Sell | S | 24.01 | 4,074 | 97,817 | 13,879 | 18 K to 13.9 K (-22.69 %) |
May 18 2009 | BCP | BALCHEM CORP | Richardson Paul H | VP, Research & Deve ... | Buy | M | 8.77 | 4,074 | 35,729 | 17,953 | 13.9 K to 18 K (+29.35 %) |
Mar 18 2009 | BCP | BALCHEM CORP | MITCHELL KENNETH P | Director | Sell | S | 20.87 | 18,748 | 391,271 | 31,018 | 49.8 K to 31 K (-37.67 %) |
Mar 18 2009 | BCP | BALCHEM CORP | MITCHELL KENNETH P | Director | Buy | M | 10.98 | 18,748 | 205,853 | 49,766 | 31 K to 49.8 K (+60.44 %) |
Mar 17 2009 | BCP | BALCHEM CORP | MITCHELL KENNETH P | Director | Sell | S | 20.57 | 1,300 | 26,738 | 31,018 | 32.3 K to 31 K (-4.02 %) |
Mar 17 2009 | BCP | BALCHEM CORP | MITCHELL KENNETH P | Director | Buy | M | 10.98 | 1,300 | 14,274 | 32,318 | 31 K to 32.3 K (+4.19 %) |
Mar 17 2009 | BCP | BALCHEM CORP | MITCHELL KENNETH P | Director | Sell | S | 20.60 | 17,963 | 369,957 | 31,018 | 49 K to 31 K (-36.67 %) |
Mar 17 2009 | BCP | BALCHEM CORP | MITCHELL KENNETH P | Director | Buy | M | 10.98 | 2,277 | 25,001 | 48,981 | 46.7 K to 49 K (+4.88 %) |
Mar 17 2009 | BCP | BALCHEM CORP | MITCHELL KENNETH P | Director | Buy | M | 7.13 | 15,686 | 111,841 | 46,704 | 31 K to 46.7 K (+50.57 %) |
Dec 15 2008 | BCP | BALCHEM CORP | WEDRAL ELAINE R | Director | Grant | A | 0.07 | 4,250 | 283 | 23,750 | 19.5 K to 23.8 K (+21.79 %) |
Dec 15 2008 | BCP | BALCHEM CORP | TELEVANTOS JOHN Y | Director | Grant | A | 0.07 | 4,250 | 283 | 24,750 | 20.5 K to 24.8 K (+20.73 %) |
Dec 15 2008 | BCP | BALCHEM CORP | ROSSI DINO A | President and CEO | Option Exercise | A | 25.92 | 40,000 | 1,036,800 | 40,000 | |
Dec 15 2008 | BCP | BALCHEM CORP | ROSSI DINO A | President and CEO | Grant | A | 0.00 | 10,000 | 0 | 81,396 | 71.4 K to 81.4 K (+14.01 %) |
Dec 15 2008 | BCP | BALCHEM CORP | Richardson Paul H | VP, Research & Deve ... | Option Exercise | A | 25.92 | 18,000 | 466,560 | 18,000 | |
Dec 15 2008 | BCP | BALCHEM CORP | Richardson Paul H | VP, Research & Deve ... | Grant | A | 0.00 | 3,000 | 0 | 13,658 | 10.7 K to 13.7 K (+28.15 %) |
Dec 15 2008 | BCP | BALCHEM CORP | Premdas Perry W | Director | Grant | A | 0.07 | 4,250 | 283 | 18,200 | 14 K to 18.2 K (+30.47 %) |